12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

• Arcutis Biotherapeutics ARQT stock moved upwards by 16.4% to $9.46 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. As per the press release, Q1 earnings came out today.
• BioAtla BCAB stock rose 13.02% to $2.95. The market value of their outstanding shares is at $141.9 million. As per the news, the Q1 earnings report came out today.
• OptimizeRx OPRX stock increased by 7.55% to $11.25. The company's market cap stands at $204.5 million. As per the news, the Q1 earnings report came out today.
• Psyence Biomedical PBM stock moved upwards by 6.74% to $0.93. The market value of their outstanding shares is at $12.4 million.
• Bone Biologics BBLG shares rose 6.08% to $2.44. The market value of their outstanding shares is at $2.1 million.
• SINTX Techs SINT stock rose 5.81% to $0.06. The market value of their outstanding shares is at $7.1 million. As per the press release, Q1 earnings came out yesterday.

Losers

• Bolt Biotherapeutics BOLT stock fell 15.9% to $1.11 during Tuesday's after-market session. The market value of their outstanding shares is at $42.3 million.
• Vivos Therapeutics VVOS stock declined by 12.86% to $2.17. The company's market cap stands at $6.4 million. The company's, Q1 earnings came out today.
• Iridex IRIX shares decreased by 12.0% to $2.71. The company's market cap stands at $44.0 million. As per the press release, Q1 earnings came out today.
• Prestige Consumer PBH stock fell 7.66% to $66.0. The market value of their outstanding shares is at $3.2 billion. As per the press release, Q4 earnings came out today.
• Akili AKLI shares decreased by 7.32% to $0.41. The market value of their outstanding shares is at $32.4 million. As per the news, the Q1 earnings report came out today.
• Ocean Biomedical OCEA shares fell 5.77% to $1.47. The market value of their outstanding shares is at $50.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.